Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement

Among hundreds of thousands of signal receptors contributing to oncogenic activation, tumorigenesis, and metastasis, the hepatocyte growth factor (HGF) receptor – also called tyrosine kinase MET – is a promising target in cancer therapy as its axis is involved in several different cancer types. It i...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xing, Li, Enliang, Shen, Hang, Wang, Xun, Tang, Tianyu, Zhang, Xiaozhen, Xu, Jian, Tang, Zengwei, Guo, Chengxiang, Bai, Xueli, Liang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218174/
https://www.ncbi.nlm.nih.gov/pubmed/32435640
http://dx.doi.org/10.3389/fcell.2020.00152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218174/
https://www.ncbi.nlm.nih.gov/pubmed/32435640
http://dx.doi.org/10.3389/fcell.2020.00152

Ejemplares similares